Fat Removal/Fat Reduction

June 18, 2012 by admin

Busy, contemporary lifestyles have translated into the presence of healthcare issues that have a global pattern. Among these, unwanted weight-gain is perhaps the commonest of health hazards and acts as a precursor for many health problems that can even take a life-threatening form. Further, being overweight is also a cosmetic deterrent since modern fashion sensibility dictates appearing fit and the presence of excess fat or cellulite makes the body look un-proportionate. However, the world of modern plastic cosmetic surgery offers some safe, effective and affordable solutions that have been explained below.

Overview of Popular Fat-removal Procedures

Liposuction is among the most common of plastic cosmetic procedures and it offers effective and long-term fat removal.

It should be understood that the conventional liposuction surgery had engaged some degree of pessimistic reviews since it put forth a considerable recovery period. The basic methodology of all liposuction methods is essentially the same wherein the cellulite or fat layers are disintegrated and then removed via suction mechanism. However, the latest of liposuction surgeries are quite progressive and don’t induce a demanding recovery phase.

 

The patient doesn’t need to undertake long-term dietary care and there are negligible chances of any complications. Liposuction is popular since it can be easily controlled for minimal or large-scale fat reduction. It is ideally suited for patients who need fat-removal at multiple sites in their body. Further, liposuction is an undemanding procedure that can is completed within a couple of hours and is often recommended for precise fat removal

View the Original article

Sedation Dentistry Offers Safe, Comfortable Dental Treatment to Fearful Patients

June 18, 2012 by admin

Despite the development of all new techniques and procedures for dental treatments, it is true that some procedures may cause real trouble for patients. Undergoing a dental check-up may not be a good experience for all patients. Probably that is why, millions of people object to a dentist visit which leads to further dental complications.

Dentists all over the world have recognized this issue and they have developed a new way to get the right treatment at the right time. Sedation dentistry is a new development in the field of dentistry. In this treatment procedure, patients are given the required drugs that minimize their fears. Many drugs are given to give a calm and relaxed state so that you can have a safe and comfortable dental treatment experience.

However, it is note here that not everyone is a good candidate for the sedation dentistry.

Dentists evaluate individual’s condition and need in order to decide what should be given in order to improve the situation. Following are few criterion that may help you to get the suitable sedation dentistry;

? The level of fear dentists or treatments
? History of earlier occurrence of dental treatments availed
? Feeling of numbness
? Vision of traumatic dental treatments
? Difficulty in opening your mouth while getting the exact treatment
? Extraordinary sensitivity in teeth
? Need for a complicated oral surgery
? Strong dislike about the environment of dental office
? Inability to make up for the dental appointments or cancels appointment often
? First-time dental treatment receiver
? Face a lot of pain while taking the dental treatment
? Sweats too much when you visit your dentist

Always go for an experienced dentist to get the right treatment who will work in according to your comfort level.

Dental

View the Original article

Comparing the Different Anti Wrinkle Eye Creams

June 19, 2012 by admin

Thanks to the intense competition in the world today, there is a lot to choose from no matter what you want. It is no different with anti wrinkle creams and you can choose from a sleuth of products that are classified on a number of different parameters. In fact, you can actually pick a cream based on your specific requirements as there is no dearth of choices in the market today. With adequate research, you should be able to understand a good anti wrinkle cream from a not so great one and decide for yourself the one that is worth your time and money.

The first parameter that you might want to consider is price. While price is by no means a measure of the quality of the product, it does help in its own way in making some decisions. A good quality cream usually costs a little bit more than the rest, but that doesn’t mean you go out and buy the most expensive cream, because that doesn’t help much.

Next, check for the ingredients of the cream.

Good brand creams are such that they use a lot of active ingredients as well as natural ones to ensure that your skin doesn’t suffer the consequences of using too many artificial ingredients and the like. You should be able to easily make this out by just looking at the packaging of the cream.

In the end, you can even consult the help of a professional to help you decide between products or read about them either on the internet or in the magazines so that you can decide for yourself what it is that you prioritize while using one of these creams.

Anti Aging

View the Original article

Role of omega-3 in preventing cognitive decline in older people questioned

ScienceDaily (June 13, 2012) — Older people who take omega-3 fish oil supplements are probably not reducing their chances of losing cognitive function, according to a new Cochrane systematic review. Based on the available data from studies lasting up to 3.5 years, the researchers concluded that the supplements offered no benefits for cognitive health over placebo capsules or margarines, but that longer term effects are worth investigating.

See Also:Health & MedicineCholesterolDietary SupplementMind & BrainIntelligenceDementiaPlants & AnimalsFoodFishLiving WellReferenceOily fishSaturated fatUnsaturated fatOmega-3 fatty acid

Omega-3 fatty acids are fats responsible for many important jobs in the body. We get these fats through our daily diets and the three major omega-3 fats are: alpha linolenic acid (ALA) from sources such as nuts and seeds and eicosapentoic acid (EPA) and docosahexaenoic acid (DHA) from sources including oily fish such as salmon and mackerel. A number of studies have hinted that omega-3 fatty acids and DHA in particular may be involved in keeping nerve cells in the brain healthy into old age. However, there is limited evidence for the role of these fats in preventing cognitive decline and dementia.

The researchers, led by Emma Sydenham at the London School of Hygiene & Tropical Medicine (LSHTM), London, UK, gathered together evidence from three high quality trials comparing the effects of omega-3 fatty acids taken in capsules or margarine spread to those of sunflower oil, olive oil or regular margarine. A total of 3,536 people over the age of 60 took part in the trials, which lasted between six and 40 months. None of the participants had any signs of poor cognitive health or dementia at the start of the trials.

The researchers found no benefit of taking the omega-3 capsules or spread over placebo capsules or spread. Participants given omega-3 did not score better in standard mental state examinations or in memory and verbal fluency tests than those given placebo.

"From these studies, there doesn't appear to be any benefit for cognitive health for older people of taking omega-3 supplements," said Alan Dangour, a nutritionist at LSHTM and co-author of the report. "However, these were relatively short-term studies, so we saw very little deterioration in cognitive function in either the intervention groups or the control groups. It may take much longer to see any effect of these supplements."

The researchers conclude that the longer term effects of omega-3 fatty acids on cognitive decline and dementia need to be explored in further studies, particularly in people with low intakes of omega-3 fatty acids in their diet. In the meantime, they stress other potential health benefits. "Fish is an important part of a healthy diet and we would still support the recommendation to eat two portions a week, including one portion of oily fish," said Dangour.

Share this story on Facebook, Twitter, and Google:

Other social bookmarking and sharing tools:

View the Original article

Diabetes: Tighter control of blood sugar prevents nerve condition, but at what risk?

ScienceDaily (June 13, 2012) — Aggressive control of blood sugar levels in diabetes can help to prevent a painful condition affecting patients' nerves, according to a new systematic review in The Cochrane Library. However, the review suggests that optimal target levels need to be established to prevent serious complications.

See Also:Health & MedicineDiabetesNeuropathyPersonalized MedicineHormone DisordersDiet and Weight LossBirth ControlReferenceBlood sugarDiabetic dietHyperglycemiaDiabetes mellitus type 2

People with diabetes control their blood sugar levels through insulin injections, diet and drugs, to compensate for their bodies producing too little insulin (type 1 diabetes) or becoming resistant to insulin (type 2 diabetes). Up to half of people with diabetes develop a disabling condition called diabetic neuropathy, which affects nerves in the feet and legs, making them feel tingly, numb, painful or weak. It is possible to prevent neuropathy by strict control of blood sugar levels through a number of ways including different insulin regimens and diet modification, but evidence for the effects of this approach, known as enhanced glucose control, has not been systematically reviewed until now.

The results analysed in the review are drawn from six studies investigating the risk of neuropathy in people who received enhanced glucose control treatments including extra insulin injections, antidiabetic drugs, and diet changes. The review looked at evidence in type 1 and type 2 diabetes separately. In two studies involving 1,228 people with type 1 diabetes significantly fewer people developed neuropathy each year with enhanced glucose control treatment compared with routine care. In four studies involving 6,669 people with type 2 diabetes the reduction in new cases of neuropathy was small and not statistically significant.

"Overall, this evidence suggests that a more aggressive approach to controlling sugar levels can be effective in delaying the onset of neuropathy in diabetes," said lead author of the review, Brian Callaghan, M.D., Assistant Professor in the Department of Neurology at the University of Michigan in Ann Arbor, Michigan, US. "The results also highlight the differences between type 1 and type 2 diabetes. The less dramatic effect of enhanced glucose control in type 2 diabetes may indicate that other factors, besides high glucose levels, may be important in causing nerve damage in these patients."

However, the risk of adverse effects associated with the treatment, including hypoglycaemia, was higher with enhanced glucose control. The researchers say further research is needed to optimise target levels for safe treatments that will both prevent neuropathy and minimise serious side effects.

"Although these results show clear benefits for preventing neuropathy in people with diabetes, they should be weighed against potential adverse effects," said Callaghan. "Future studies must establish target levels for glucose control that will balance benefits and side effects."

Share this story on Facebook, Twitter, and Google:

Other social bookmarking and sharing tools:

View the Original article

HIV-positive saliva not a "deadly weapon": NY court

Yahoo! News Search Search Web HomeVideoPhotosGMAYear in ReviewOddComicsTravelOpinionTrending NowWho Knew?Weatheru.s.U.S. VideoGMAEducationReligionCrimes and TrialsThe LookoutSept. 11LocalContributor NetworkYear in ReviewworldWorld VideoMiddle EastEuropeLatin AmericaAfricaAsiaCanadaAustralia/AntarcticabusinessVideoExclusivesToday's MarketsStocksPersonal FinancePress ReleasesMarketplaceNewsmakersentertainmentVideoClinton ConcertCelebrityTVMoviesMusicReviewsFashionBooksArtsTheaterDear AbbyComicsOdd NewssportsVideoNFLMLBNBANCAAFNCAABSoccerCyclingNHLTennisGolfBoxingMotor SportsMMAExtremetechBlogTech It UpBest in TechGadgetsWirelessAppleSocial MediaSecurityOpen SourceGamingAppsUpgrade Your LifepoliticsDestination 2012The TicketThe SignalRemake AmericaThe IssuesElection MapWhite HouseCongressThe CourtsWomen and PoliticsPress ReleasesVideoscienceScience VideoWeather NewsSpace / AstronomyPetsDinosaurs / FossilsBiotechEnergyGreenhealthVideoWeight LossCancerSexual HealthMedications/DrugsParenting/KidsSeniors/AgingDiseases/ConditionsBlogsThe UpshotThe CutlineThe LookoutThe SideshowThe TicketAround the WorldKatie's TakePower PlayersThis Could Be BigNewsmakersTrending NowLocalPopular SearchKeywordNews Search Featured»VideosPhotosTrending NowKatie's TakeTech it up!WeatherWho Knew?Power PlayersRemake America Discover Yahoo! With Your Friends

Explore news, videos, and much more based on what your friends are reading and watching. Publish your own activity and retain full control.

To get started, firstLogin with Facebook YOUR FRIENDS' ACTIVITY prev next HIV-positive saliva not a "deadly weapon": NY court

View the Original article

Girl jabbed in foot by syringe at Washington state hotel

"background-image:url('http://l3.yimg.com/bt/api/res/1.2/qDc3ibMaasSVn72vKfHpKQ--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTcwO3B5b2ZmPTA7cT04NTt3PTcw/http://media.zenfs.com/en_us/News/ap_webfeeds/e714313e9d1b7410120f6a706700455c.jpg');" width

View the Original article

Baby Boomers and Drug-Resistant Gonorrhea

Yahoo! Contributor Network – Thu, Jun 7, 2012 Baby boomers take heed: Drug-resistant gonorrhea may well be a topic of interest or concern to you.

STD Numbers on Upswing for Baby Boomers

A February report by UPI.com revealed that researchers in the United States, Canada and England discovered an upswing in the numbers of baby boomers reporting sexually transmitted diseases, including chlamydia, syphilis and gonorrhea. Researchers theorize that in addition to many people in this age group not practicing safe sex, post-menopausal women are at greater risk for micro-tears due to decreased lubrication, with the tiny tears providing entry portals for the infectious organisms.

Health Care Providers Put on Notice

On Wednesday, the United Nations' health agency, the World Health Organization, put health care providers around the world on notice about being vigilant in their surveillance of the antibiotic-resistant strain of gonorrhea that is expected to eventually be found throughout the world. According to an AP report, the drug-resistant strain of gonorrhea has currently been identified in nations such as Norway, Japan and Britain.

What's the Risk?

Currently, the drug-resistant strain that concerns health experts has been developing a resistance to all the antibiotics currently used to treat this STD. As this strain of gonorrhea continues to develop and mutate, it is likely to become immune to all current treatments, reports Forbes.com. This could result in an incurable form of a sexually transmitted disease that is the second-highest reported communicable disease in the United States.

Bottom Line

Baby boomers didn't have to be concerned about deadly types of STDs during the heyday of their youth, so it can seem like those "teenagers" diseases aren't a concern in mid-life. Safe sex is important for sexually active adults at any age, as well as taking antibiotics for any condition exactly as prescribed to help avoid the development of future "super germs."

Smack dab in the middle of the baby boomer generation, L.L. Woodard is a proud resident of "The Red Man" state. With what he hopes is an everyman's view of life's concerns both in his state and throughout the nation, Woodard presents facts and opinions based on common-sense solutions.

View the Original article

Rising Hope for AIDS Cure

I remember having a conversation with a friend of mine a couple of years ago regarding the discovery of a genetic mutation that makes people resistant to HIV. It was an email conversation, complete with many exclamation points, a sign of the times both in communication and in the promise of a cure for AIDS in our lifetime. Now, that promise is a little closer to becoming a reality.

According to ABC News, a 46-year-old man named Timothy Brown, diagnosed with AIDS, received a transplant of blood stem cells to treat leukemia in 2007. The adult blood donor had this HIV-resistant gene mutation. Brown is now the only person in the world to be cured of AIDS. But there will be more.

According to Dr. Lawrence Petz, the medical director for the umbilical cord blood bank StemCyte, the process is complicated by the fact that this HIV-resistant mutation is very rare, with fewer than 1 percent of Caucasians having it, and even fewer individuals of other races. Brown's transplant involved a very close donor match. However, umbilical cord blood doesn't require as close of a match. But it does require the rare mutation and Petz and his colleagues have only discovered 102 umbilical cord blood samples in 17,000 tested that contain it.

Within the past few weeks, an HIV-infected patient received a cord blood transplant. Another is planned later this year. It will take months to know if these patients will see an impact from the transplants as Brown did. But Petz is hopeful. He says that the cure can happen. It's just a matter of time.

I believe that the promise is much brighter with this advancement. I believe, as Petz and Brown believe, that there will be a cure for AIDS, for all people suffering from AIDS. It may take a bit longer to come, but it is happening. And that's a wonderful thing. A hopeful thing.

View the Original article

FDA delays decision on first drug to prevent HIV

Federal health regulators have delayed a decision on whether to approve the first pill shown to prevent HIV infection, the drug's manufacturer says.

Gilead Sciences disclosed Friday that the Food and Drug Administration will take three more months to review its application for Truvada, after the company submitted additional materials to the agency earlier this month.

In May, a panel of experts recommended approval of the daily pill for healthy people who are at high risk of contracting HIV, including gay and bisexual men. The vote was nonbinding, though the FDA often follows the group's advice.

Gilead said it submitted updated information on its planned safety materials for patients and doctors using the drug. The FDA typically extends its reviews after receiving such information.

The FDA is now expected to rule by Sept. 14, the company said in a statement.

Gilead Sciences Inc., based in Foster City, Calif., has marketed Truvada since 2004 as a treatment for people who are infected with the virus. The medication is a combination of two older HIV drugs, Emtriva and Viread.

Truvada made headlines in 2010, when government researchers showed it could actually prevent people from contracting HIV when used as a precautionary measure. A three-year study found that daily doses cut the risk of infection in healthy gay and bisexual men by 42 percent, when accompanied by condoms and counseling. Last year another study found that Truvada reduced infection by 75 percent in heterosexual couples in which one partner was infected with HIV and the other was not.

An estimated 1.2 million Americans have HIV, which develops into AIDS unless treated with antiviral drugs. AIDS causes the body's immune system to break down, leading to infections which are eventually fatal. Gay and bisexual men account for the majority of cases

View the Original article

Revealed: Secret of HIV's natural born killers

'modId':'mediasocialchromefriends','isPreLoad':0,'enableMediaTabEvent':0,'pageSize':12,'numFriends':null,'notificationCount':0,'property':'News','learnMorePath':'/activity-learn-more/','friendbarNotification':'0','friendbarRollup':'0','moduleConf':YAHOO.Media.Facebook.ModuleConf,'friendIdList':

View the Original article

Superbug gonorrhea spreading across Europe

Reuters – Mon, Jun 11, 2012 LONDON (Reuters) - "Superbug" strains of gonorrhea which are becoming untreatable accounted for almost one in 10 cases of the sexually transmitted disease in Europe in 2010, more than double the rate of the year before, health officials said on Monday.

The drug-resistant strains are also spreading fast across the continent, officials warned. They were found in 17 European countries in 2010, seven more than in the previous year.

Gonorrhea was the second most common sexually transmitted infection (STI) in Europe in 2010, with more than 32,000 infections, data from the Stockholm-based European Centre for Disease Prevention and Control (ECDC) showed.

Even though chlamydia was the most frequently reported STI, with more than 345,000 cases, the ECDC's director singled out gonorrhea as presenting a "critical situation".

Marc Sprenger said the increase in cases of superbug strains meant there was a risk gonorrhea may become an untreatable disease in the near future.

The proportion of gonorrhea cases with resistance to the antibiotic recommended to treat the disease, cefixime, rose from 4 percent in 2009 to 9 percent in 2010.

The ECDC report follows a warning from the World Health Organisation that virtually untreatable forms of drug-resistant gonorrhea were spreading around the world.

Gonorrhea is a bacterial infection which, if left untreated, can lead to pelvic inflammatory disease, ectopic pregnancies, stillbirths, severe eye infections in babies, and infertility in men and women.

VIGILANT

It is one of the most common sexually transmitted diseases in the world and is most prevalent in South and Southeast Asia and sub-Saharan Africa.

In the United States alone, the number of cases is estimated at about 700,000 a year, according to the Centers for Disease Control and Prevention (CDC).

The emergence of drug-resistant gonorrhea is caused by unregulated access to and overuse of antibiotics, which help fuel genetic mutations within the bacteria.

"Public health experts and clinicians need to be aware of the current critical situation and should be vigilant for treatment failures," Sprenger said in a statement.

Experts say the best way to reduce the risk of even greater resistance developing - beyond the urgent need to develop new drugs - is to rapidly and accurately diagnose the disease and then treat it with combinations of two or more types of antibiotics at the same time.

This technique is used in the treatment of some other infections like tuberculosis in an attempt to make it more difficult for the bacteria to learn how to overcome the drugs.

The ECDC's sexually transmitted infections report covered data and trends on five STIs - syphilis, congenital syphilis, gonorrhea, chlamydia and lymphogranuloma venereum (LGV) - in the EU and European Economic Area from 1990 to 2010.

It found diverging trends in sexually transmitted diseases across Europe, with a rapidly increasing trend for chlamydia and slightly decreasing trends for gonorrhea and syphilis.

Genital chlamydia infections are caused by Chlamydia trachomatis bacteria which can irreversibly damage a woman's reproductive organs.

Although the disease is easily treated with antibiotics, infections can remain undiagnosed because many patients - 70 percent of women and 50 percent of men - have no symptoms and so are unaware they are carrying and passing on the infection.

(Editing by Pravin Char)

View the Original article